To confirm whether mROS promoted GSDMD oligomerization in lupus mice, Mito-TEMPO was continuously administered prophylactically for seven weeks via subcutaneous pump to MLR/lpr lupus mice, starting at 10 weeks of age. Here, GSDMD is linked to systemic lupus erythematosus.